Improving Hypertension Control in Rheumatoid Arthritis

Part of paid clinical trials in Durham, North Carolina.

Sponsor
Duke University
Study ID
NCT05760898
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Blood pressure intervention arm — BEHAVIORAL
    The intervention will focus on empowering patients to actively participate in their HTN care, facilitating patient-provider communication, and creating a cohesive care team to close the coordination loop for HTN management. This pilot intervention will help achieve these goals by providing participants with home blood pressure monitors and teaching, improving patient-provider communication regarding blood pressure and RA management, and initiating care coordination between rheumatology and primary care providers.

Study Details

Rheumatoid arthritis (RA) is a autoimmune disease associated with an increased risk of developing coronary artery disease (CAD) and premature death,. Traditional CAD risk factors like hypertension (HTN) are both very common and poorly controlled among RA patients. Patients with RA face significant challenges in controlling HTN. The goal of this project is to identify barriers to HTN care in patients with RA to reduce CAD events.

Key Dates

Start date
Jan 16, 2026
Status verified
Aug 2025
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
25 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Blood pressure intervention arm
    The investigators will recruit 25 RA patients with HTN for the study. Participants will be provided with a home blood pressure monitor, teaching from nursing staff regarding the correct use of the monitor, and a guide to help interpret normal and elevated blood pressure values. Participants will be instructed to obtain and record blood pressure values at least three times per week over the course of 3 months. Every 2 weeks, these results will be sent to the study team, and participants will complete a brief survey regarding other factors that may influence blood pressure control, including RA disease activity (RAPID3 score), pain, current use of acute RA therapies, anti-hypertensive medication use, anti-hypertensive medication adherence, and current perceived barriers to HTN self-management.

Primary Outcome Measure

Intervention feasibility as measured by participant accrual rates [ Time Frame: 6 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Duke Health SystemDurhamNorth Carolina27710
Edna Scarlett
[email protected]
919-684-6150
Isaac Smith, MD
[email protected]
919-613-2243
Isaac Smith, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Durham, NC

By condition
Hypertension (high blood pressure)Rheumatoid arthritis
By specialty
CardiologyHeart diseaseRheumatologyAutoimmune diseaseMusculoskeletal disorders
By research site
Duke Health System· Durham, NC

Related Studies